Number of Circulating CD 73-Expressing Lymphocytes Correlates With Survival After Cardiac Arrest.
Sergey Ryzhov, Teresa May, John Dziodzio...
https://pubmed.ncbi.nlm.nih.gov/31237169/Actively Recruiting
Led by MaineHealth · Updated on 2025-07-18
400
Participants Needed
1
Research Sites
52 weeks
Total Duration
Researchers are investigating the immune and metabolic responses after cardiac arrest to better understand how inflammation and metabolism affect brain injury, survival, and recovery. This observational study focuses on the changes in immune cells and inflammatory pathways that may influence neurological outcomes and explores metabolic factors like brown adipose tissue activity, which could play a role in recovery. The study aims to clarify how these biological responses relate to different clinical outcomes after cardiac arrest. Participants will have blood samples taken daily for seven days following their cardiac arrest to analyze immune cell populations and inflammatory markers. The study will track patient clinical details and outcomes, examining links between immune responses and neurological or cardiac injury. Metabolic activity, such as brown fat function, will also be studied over two weeks to understand its impact on recovery and inflammation. During the study, participants will undergo regular blood sampling and clinical evaluations to collect data on immune cells, inflammatory markers, and metabolic activity. Researchers will measure correlations between these biological factors and clinical outcomes over 7 to 14 days. The study includes monitoring of neurological and cardiac injury markers and aims to identify mechanisms behind post-resuscitation inflammation and metabolism. Participation duration varies, with ongoing data collection within the first two weeks after cardiac arrest.
CONDITIONS
Immunoinflammatory Response in Post Cardiac Arrest Syndrome (PCAS)
D
David B Seder, MD
S
Sergey Ryzhov, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
MaineHealth
Lead Sponsor
National Institute of General Medical Sciences (NIGMS)
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 7 days
Participants undergo blood sampling and assessments to measure immune cell populations and inflammatory markers after resuscitation.
Multiple visits during the first week
Duration - Up to 14 days
Participants are observed to correlate inflammatory markers and metabolic activity with neurological and cardiac outcomes over time.
Follow-up visits during the two weeks after cardiac arrest
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Have more questions? Get in touch with our team for quick support
Sergey Ryzhov, Teresa May, John Dziodzio...
https://pubmed.ncbi.nlm.nih.gov/31237169/Joanne T deKay, Elena Chepurko, Vadim Chepurko...
https://pubmed.ncbi.nlm.nih.gov/38325139/MaineHealth
Lead Sponsor
National Institute of General Medical Sciences (NIGMS)
Collaborating Sponsor